February 2026 Br J Cardiol 2026;33(1) doi:10.5837/bjc.2026.009 Online First
Hugh Lurcott, Sarah O’Connell, Lynn Almasri, Asma Khan, Michael Dodkin, M Zeeshan Khawaja
At our tertiary PCI centre in London, we conducted a retrospective audit of all patients admitted under the acute medical take with a diagnosis of non-ST-elevation – acute coronary syndrome (NSTE-ACS) between October 2023 and October 2024. As per our Trust pathway, patients with NSTE-ACS were admitted under acute medicine, rather than cardiology, if they did not have significant dynamic electrocardiogram (ECG) changes, ongoing chest pain, pulmonary oedema, cardiogenic shock, ventricular arrhythmias or a history of coronary intervention in the preceding 30 days. In total, 74 patients underwent coronary angiography with a mean age of 64.2 ±
September 2023 Br J Cardiol 2023;30:106–7 doi:10.5837/bjc.2023.028
Kerrick Hesse, Zaw Htet, Mickey Jachuck, Nicholas Jenkins
Introduction Undifferentiated chest pain places a significant burden on the UK National Health Service (NHS). Up to 50% of the general population experiences chest pain in their lifetime contributing to at least 1% of GP consultations and 5% of accident and emergency (A&E) attendances.1 Chest pain patients have a twofold higher mortality versus age-matched asymptomatic controls.1 One reason is undiagnosed obstructive coronary artery disease (CAD), which has effective treatments to prolong life and improve symptoms.1 The challenge is identifying the patients at greatest risk, providing a timely diagnosis and starting effective treatment. T
August 2016 Br J Cardiol 2016;23:110–3 doi:10.5837/bjc.2016.028
Peregrine Green, Paul Frobisher, Steve Ramcharitar
(more…)
You need to be a member to print this page.
Find out more about our membership benefits
You need to be a member to download PDF's.
Find out more about our membership benefits